Coacervate‐Filled Lipid Vesicles for Protein Delivery
Abstract
Macromolecularly crowded coacervate is useful in protein delivery for tissue engineering and regenerative medicine. However, coacervate tends to aggregate easily, which impedes their application. Here, this work presents a method to prepare coacervate with enhanced stability. This work assembles phospholipids on the surface of a coacervate to form lipocoacervate (LipCo). The resultant LipCo possesses a discrete spherical structure with a coacervate interior and phospholipid outer shell. The size of LipCo does not change over the four‐week observation window, whereas coacervate coalesced into one bulk phase within 30 min. This work uses vascular endothelial growth factor‐C (VEGF‐C) and fibroblast growth factor‐2 (FGF‐2) as examples to test LipCo's ability to maintain protein bioactivity. The in vitro lymphangiogenesis assay demonstrates that human dermal lymphatic endothelial cells (LECs) formed increased network of cord in VEGF‐C and FGF‐2 loaded LipCo group compared to free proteins and proteins loaded in coacervate. Overall, LipCo could serve as a protein delivery vehicle with improved colloidal stability.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 19, 2023
- Source ID
- 10.1002/mabi.202200538
Entities
People
- Chia‐Wei Yeh
- Yadong Wang
Organizations
- Congressionally Directed Medical Research Programs
- Cornell University
- National Science Foundation